This is therefore a contrasting of the risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation in LeMaitre Vascular Inc. (NASDAQ:LMAT) and Pulse Biosciences Inc. (NASDAQ:PLSE). The two are both Medical Instruments & Supplies companies that compete with one another.

Valuation and Earnings

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular Inc.	105.57M	5.55	22.94M	1.11	27.00
Pulse Biosciences Inc.	N/A	0.00	37.55M	-2.20	0.00

Table 1 demonstrates LeMaitre Vascular Inc. and Pulse Biosciences Inc.’s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 has LeMaitre Vascular Inc. and Pulse Biosciences Inc.’s return on assets, return on equity and net margins.

	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular Inc.	21.73%	18.7%	16.3%
Pulse Biosciences Inc.	0.00%	-90.6%	-81.5%

Liquidity

The Current Ratio and Quick Ratio of LeMaitre Vascular Inc. are 5.9 and 4.4 respectively. Its competitor Pulse Biosciences Inc.’s Current Ratio is 6.6 and its Quick Ratio is 6.6. Pulse Biosciences Inc. can pay off short and long-term obligations better than LeMaitre Vascular Inc.

Dividends

LeMaitre Vascular Inc. pays out a $0.28 per share dividend on a yearly basis and it also offers 0.93% dividend yield. No dividend is paid out by Pulse Biosciences Inc.

Analyst Recommendations

LeMaitre Vascular Inc. and Pulse Biosciences Inc. Recommendations and Ratings are available in the next table.

	Sell Ratings	Hold Ratings	Buy Ratings	Rating Score
LeMaitre Vascular Inc.	0	2	1	2.33
Pulse Biosciences Inc.	0	0	0	0.00

LeMaitre Vascular Inc.’s downside potential currently stands at -8.35% and an $27.33 consensus target price.

Institutional and Insider Ownership

Institutional investors held 78.8% of LeMaitre Vascular Inc. shares and 8.7% of Pulse Biosciences Inc. shares. About 17.3% of LeMaitre Vascular Inc.’s share are held by insiders. On the other hand, insiders held about 42.8% of Pulse Biosciences Inc.’s shares.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
LeMaitre Vascular Inc.	0.23%	26.17%	6.06%	-16.56%	-11.92%	27.24%
Pulse Biosciences Inc.	-0.06%	35.1%	41.57%	28.2%	-0.17%	57.5%

For the past year LeMaitre Vascular Inc.’s stock price has smaller growth than Pulse Biosciences Inc.

Summary

LeMaitre Vascular Inc. beats Pulse Biosciences Inc. on 10 of the 12 factors.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patientÂ’s body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove plaque from arteries in the leg. Further, it offers valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches, which are used for precision endarterectomy vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Pulse Biosciences, Inc., a medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in dermatology/aesthetics, oncology, minimally invasive ablation, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Burlingame, California.